AI skin analysis market is led by L'Oréal as competition fragments

By AI, Created 5:20 PM UTC, May 18, 2026, /AGP/ – The AI skin analysis instruments market is still fragmented, with L’Oréal holding the top global sales position in 2024 and the top 10 players controlling just 14% of revenue. The latest market snapshot points to growing demand for AI-based dermatology tools, deeper image analysis and more personalized skincare workflows.

Why it matters: - AI skin analysis instruments are moving from novelty tools to core dermatology and skincare technology. - The market matters because it links consumer beauty, clinical assessment and AI-driven diagnostics. - Companies that win here can shape personalized skincare recommendations, treatment planning and digital dermatology workflows.

What happened: - The Business Research Company said the global AI skin analysis instruments market is dominated by global dermatology device makers and specialized AI skincare technology providers. - L’Oréal S.A. led global sales in 2024 with a 7% market share. - The market remained fairly fragmented in 2024, with the top 10 players accounting for 14% of total revenue. - The report listed L’Oréal S.A., Perfect Corp., Shiseido Company, Limited, Galderma (Cetaphil), Meitu Inc., Revieve Skincare, Canfield Scientific Inc., Haut.AI OÜ, HiMirror and Zemits Inc. as leading companies.

The details: - Companies are focusing on image-based skin diagnostics, deep learning analysis algorithms, non-invasive imaging instruments and integrated digital skincare assessment platforms. - Clinical validation, patient data privacy and AI-enabled decision support remain central to competitive positioning. - The report said moderate barriers to entry come from privacy rules, clinical validation standards, algorithm accuracy and reliability requirements in dermatology and cosmetic analysis. - L’Oréal’s dermatological beauty technology division offers AI-powered skin diagnostics tools, digital skin imaging devices, personalized skincare analysis solutions and dermatology-focused software platforms. - Other major companies in the market include Meitu Inc., Revieve Skincare, Canfield Scientific Inc., Haut.AI OÜ, SkinVision B.V., FotoFinder Systems GmbH, MetaOptima Technology Inc., FOREO AB, Beijing ADSS Development Co. Ltd., Shanghai May Skin Information Technology Co. Ltd., Skinive AI Scanner and Amway. - Major raw material suppliers include Intel, NVIDIA, Qualcomm, AMD, STMicroelectronics, Texas Instruments, NXP Semiconductors, Infineon, Sony Semiconductor Solutions, Samsung Electronics, Canon, OmniVision, Himax, Microchip, ON Semiconductor, Analog Devices, Renesas and MediaTek. - Major wholesalers and distributors include Arrow Electronics, Avnet, Ingram Micro, Tech Data, Synnex, Digi-Key, Mouser, Future Electronics, RS Group, Newark, TTI, ScanSource, Macnica, Westcon Group, Exclusive Networks, ALSO Holding, Esprinet, Redington, Bechtle, Cancom, Insight, CDW, Softchoice, Mindware and EET Group. - Major end users include L’Oréal, Shiseido, Estée Lauder, Procter & Gamble, Unilever, Johnson & Johnson Consumer Health, Beiersdorf, Amorepacific, Oriflame, Natura & Co, Nu Skin, Clarins, Sephora, Ulta Beauty, Dermalogica, Murad, Galderma, Revieve, Perfect Corp., Canfield Scientific, Alma Lasers, Cynosure, Lumenis and Cutera. - The report highlighted AI-powered digital skin analysis systems as a driver of biomarker-based assessment, greater diagnostic precision and more personalized skincare recommendations. - In April 2024, NAOS launched Skin Observer with Haut.AI, a digital skin analysis platform for clinical-grade skin evaluation. - The platform’s computer vision and machine learning models analyze more than 150 skin biomarkers and support personalized routines, progress tracking and data-driven product recommendations.

Between the lines: - The market structure suggests no single company has locked up the category, even with L’Oréal in front. - Fragmentation gives room for partnerships, product launches and regional expansion to move market share. - The emphasis on privacy and validation shows that technical capability alone is not enough in skin diagnostics. - The use of AI in both consumer skincare and clinical evaluation suggests the category is converging across beauty and healthcare.

What’s next: - The report expects strategic collaborations, product innovation and regional expansion to strengthen leading companies. - Demand for AI-enabled skin assessment tools, real-time facial analysis systems and personalized dermatology solutions is expected to keep rising. - More platforms will likely compete on accuracy, biomarker coverage and clinical utility. - The full report is available here and a sample request is available here.

The bottom line: - AI skin analysis is becoming a contested diagnostics and personalization market, not just a beauty-tech niche.